Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
After the EU announced the imposition of high anti-dumping duties, Sanyuan Biological responded to the USA's "double anti" investigation | Read the announcement quickly.
① Sanyuan Bio estimated that during the anti-dumping investigation, the amount of erythritol involved in the USA "double anti" investigation accounted for about 20.18% of the company's revenue; ② Industry insiders said that Sanyuan Bio has the highest global share of erythritol, with a large overseas market size and lower export prices, making it more prone to overseas investigations.
Has the anti-dumping investigation come to a conclusion? The EU announces the final tax rate on imported erythritol from China, with mixed reactions from Baolingbao Biology and Sanyuan Biological | Quick read announcement.
① The EU announced the final ruling results of the anti-dumping investigation into erythritol products originating from China, with Sanyuan Bio and Baolingbao Biology being subjected to different tax rates, leading to mixed feelings. ② Baolingbao Biology stated it will actively expand into the EU market, while Sanyuan Bio indicated it will promote new products in the EU and strengthen development in the domestic market.
The State-owned Assets Supervision and Administration Commission and the National Development and Reform Commission jointly issued significant venture capital policies, and the equity market is expected to enter a period of development and prosperity.
① The State-owned Assets Supervision and Administration Commission (SASAC) and the National Development and Reform Commission jointly issued policy measures to promote the high-quality development of venture capital funds by central enterprises, supporting these enterprises to initiate and establish venture capital funds, focusing on early-stage, small-scale, long-term investments, and hard technology. ② Citic sec research reports indicate that in the context of the secondary market entering a valuation expansion cycle, with the increasing linkage effect between the primary and secondary markets, the equity market will also move towards a prosperous period of high-quality development.
China’s Sinopec, Sinochem Secure Multi-Year US LNG Deals
China's Paper-Making Sector Posts Double-Digit Jump in Nine-Month Profit, Revenue